Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.
We synthesized Cryptococcus neoformans serotype A glucuronoxylomannan (GXM) conjugate vaccines under conditions suitable for human use to prevent disseminated cryptococcosis. The purified, sonicated GXM was derivatized with adipic acid dihydrazide through either hydroxyl or carboxyl groups and then...
Sparad:
| I publikationen: | Infect Immun |
|---|---|
| Huvudupphov: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
1991
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC258941/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1716613/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.59.10.3700-3707.1991 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
